In laying out the Trump administration's strategy for reducing drug prices, HHS Secretary Alex Azar suggested pumping up Medicare Part D by moving some expensive drugs out of Part B. All 59 million Medicare beneficiaries are eligible for Part D, with roughly 71% enrolled in the program. Download the PDF.
Data Points: Medicare Part D not immune to price hikes
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You